Loading organizations...
§ Venture Capital · Branford, CT, USA
Venture capital firm investing in early-stage seed and Series A companies within medical technology and life sciences.
Cycle Venture Partners is a venture capital firm investing in early-stage biotechnology companies across the United States. The firm focuses on innovative ventures in drug discovery, advanced diagnostics, and other life sciences, providing capital and strategic support. Its approach fosters promising technologies from initial development through critical growth.
Alan Kersey founded Cycle Venture Partners in 2017. His insight recognized the unique capital and operational support required by nascent biotechnology companies to transition scientific breakthroughs into commercial realities. Kersey, a seasoned investor, established the firm to accelerate the development of therapeutic and diagnostic platforms.
The firm partners with entrepreneurs and management teams building high-potential biotechnology startups. Cycle Venture Partners aims to foster their growth, enabling them to translate complex research into tangible medical solutions. Its long-term vision centers on advancing healthcare innovation through strategic capital deployment and active collaboration.
Cycle Venture Partners has 2 tracked investments across 2 companies. The latest tracked deal is $4.3M Series A in Lumeda in April 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 8, 2021 | Lumeda | $4.3M Series A | Connecticut Innovations | — |
| Jun 20, 2019 | Cybrexa Therapeutics | $13.4M Series B | — | Connecticut Innovations, Highcape Capital |